Pfizer’s Arena Pharma deal may lead drug company to a cannabis-based treatment
December 23, 2021 at 12:01 PM EST
Pfizer's pending acquisition of Arena Pharma includes Olorinab, a candidate that acts with the cannabinoid type 2 receptor to treat gastrointestinal disorders.
